Skip to main content

ORIGINAL RESEARCH article

Front. Public Health, 16 January 2025
Sec. Public Health Policy
This article is part of the Research Topic Public Health Challenges in Post-Soviet Countries During and Beyond COVID-19, Volume II View all 4 articles

Hantavirus antibody seroprevalence and risk factors among adults in West Kazakhstan, 2023

  • 1Scientific and Practical Center for Sanitary-Epidemiological Expertise and Monitoring, Almaty, Kazakhstan
  • 2Central Asia Field Epidemiology Training Program, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
  • 3Project Implementation Unit of the Global Fund to Fight AIDS, Tuberculosis and Malaria in Kazakhstan, Almaty, Kazakhstan
  • 4Division of Global Health Protection in Central Asia, United States Centers for Disease Control and Prevention, Almaty, Kazakhstan
  • 5S. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
  • 6M. Aikimbayev’s National Scientific Center of Especially Dangerous Infections, Almaty, Kazakhstan
  • 7International Institution of Postgraduate Education, Almaty, Kazakhstan
  • 8Reference Laboratory for the Control of Especially Dangerous Infections, Almaty, Kazakhstan
  • 9Ural Anti-Plague Station, Uralsk, Kazakhstan
  • 10National Center for Public Health, Astana, Kazakhstan
  • 11University of Texas Medical Center, Galveston, TX, United States
  • 12Infectious Diseases Research, Abbott Diagnostics, Abbott Park, IL, United States
  • 13Abbott Pandemic Defense Coalition (APDC), Abbott Park, IL, United States
  • 14Department of Global Health, Emory Rollins School of Public Health, Atlanta, GA, United States

Background: Orthohantaviruses (also known as hantaviruses) are pathogens, primarily transmitted by rodents, that can cause hemorrhagic fever with renal syndrome (HFRS). In endemic regions of Kazakhstan, no confirmed HFRS cases were detected between 2020 and 2022 raising concerns about detection. Estimate antibody seroprevalence for hantaviruses and identify associated risk factors among high-risk adults in western Kazakhstan in 2023.

Methods: In this cross-sectional study, adults were randomly sampled from public clinic registries in 14 villages in West Kazakhstan during June–July 2023. We interviewed 921 participants and collected serum samples which were tested for presence of hantavirus specific IgG antibodies using enzyme-linked immunosorbent assay (ELISA). Socio-demographic, clinical characteristics, and residential risk-factor data were self-reported. We assessed factors associated with seropositivity using multivariable Poisson regression, adjusting for key variables such as age and gender.

Results: Among 921 participants, 63.0% were female, median age was 53 years, 72.0% resided in single houses and 38.0% reported encounters with rodents. Among 921 participants we found 3.1% (n = 28) hantavirus seroprevalence (95% confidence interval [CI]: 2.1–4.3). No seropositive participants had prior hospitalization or symptoms consistent with hantavirus. Three seronegative participants had previous hospitalization for hemorrhagic fever with renal syndrome. Over one-third (38%) of participants encountered rodents or droppings in the past year in their homes or workplaces. Higher seroprevalence was found among office occupational workers than unemployed people (prevalence ratio [PR]:7.3, 95%CI: 1.3–53.5), and among those who lived near ponds than those who did not (PR:11.5, 95%CI: 1.6–54.7).

Conclusion: Overall, the seroprevalence was low, but indicated some risk of infection among the adult population. Our results highlight potential occupational and residential risk factors for hantavirus infection in West Kazakhstan. Relevant public health interventions should include educating the population about promoting preventive practices, workplace hygiene, rodent control measures, and enhanced case diagnosis and management.

1 Introduction

Orthohantaviruses, also known as hantaviruses, are a group of zoonotic pathogens known for causing hantavirus infection in humans. These viruses predominantly transmit through contact with infected rodents and from inhalation of aerosolized viral particles from urine, droppings or saliva (1). In the Americas, hantavirus infection leads to hantavirus pulmonary syndrome, a severe cardiopulmonary disease (2). In Africa, Asia and Europe, it causes hemorrhagic fever with renal syndrome (HFRS) and nephropathia epidemica (NE) (3). Russia has the highest burden with an average of over 164,000 cases reported annually (4), followed by China which reports on average 10,000 cases annually (5). HFRS can be caused by Hantaan virus (HTNV), Amur virus, Seoul virus (SEOV), Dobrava-Belgrade virus (DOBV), or Puumala virus (PUUV) strains. Each has variable clinical presentations and a range of severity (68).

Rural communities are usually at higher risk for HFRS than urban areas due to proximity to natural rodent habitats and often poorer sanitary conditions, which increase the likelihood of contact with rodents (9, 10). The population of the West Kazakhstan region is predominantly rural and is known to have increased risk for HFRS compared to other regions of Kazakhstan (11). The first human cases in West Kazakhstan were detected and serologically confirmed in 2000. By 2023, 251 cases had been confirmed in the region (Figure 1). West Kazakhstan region has a population of 683,327 and borders Russia near the Ural Mountains. The region has a unique habitat of flora and fauna, that may be favorable to species that can carry hantaviruses and other zoonotic infections (11, 12). Recent studies on the prevalence of antibodies to hantaviruses among host reservoirs (primary rodents) in Kazakhstan indicate that the virus is circulating in the areas previously considered free of them (1315).

Figure 1
www.frontiersin.org

Figure 1. Surveyed study areas with location of selected villages in West Kazakhstan region, 2023.

The healthcare system in the region includes district central hospitals and a regional infectious diseases hospital in the city of Uralsk. When healthcare workers suspect a person has HFRS, they are admitted to the regional infectious disease hospital for testing. Samples are sent to the Ural anti-plague station which is the only laboratory in West Kazakhstan with capacity to run HFRS ELISA IgM and IgG.

In Kazakhstan the average incidence rate was 0.04 per 100,000 population over the past 20 years with the peak registered cases in 2005 due to the outbreak related to the increase in the number of rodents due to drought (Figure 2).

Figure 2
www.frontiersin.org

Figure 2. Registered cases of hemorrhagic fever with renal syndrome in Kazakhstan, 2000–2023.

No confirmed HFRS cases were reported to the national surveillance system between 2020 and 2022, raising concerns about potential underreporting and delayed detection. The redirection of resources to deal with the COVID-19 pandemic may have resulted in decreased surveillance and reporting of other reportable diseases, including HFRS, during this period (16).

The goal of our study was to investigate the seroprevalence of hantavirus infection in West Kazakhstan to better understand the burden and identify possible risk factors to hantavirus infection in the region.

2 Methods

2.1 Study design

We conducted a cross-sectional seroprevalence study during June–July 2023 in 14 villages in Bayterek and Boryly districts in the West Kazakhstan region (Figure 1). These villages were selected because they were considered high-risk areas for hantavirus transmission over the past decade.

The study population included persons aged 18 years and older residing in villages in the two districts. Sample size was calculated by Kauermann et al. (17) method. We used systematic random sampling to select a minimum of 900 participants from public clinic registries. In Kazakhstan, all people living in a public clinic’s catchment population are registered at that clinic. Selected participants were recruited by telephone and asked to come for an appointment at their local clinic. To ensure inclusivity, particularly for individuals residing in remote areas, participants were invited to visit the centers at times convenient for them. A total of 921 individuals formed the final study population.

2.2 Data sources

2.2.1 Survey tool

Trained nurses conducted face-to-face interviews. The questionnaire included questions about socio-demographic, clinical characteristics, and environmental and behavioral risk factors associated with hantavirus infection. Data entry was done using KoboToolBox (Kobo Organization, Cambridge, Massachusetts, USA) (18).

2.2.2 Laboratory tests

We collected approximately 5 mL of whole blood from consenting participants. Samples were transported to the Ural anti-plague laboratory at +2°C to +4°C within 2–4 h of collection. There, samples were centrifuged, serum samples were aliquoted into two cryovials, and frozen at −20°C. Frozen samples were transported to the Especially Dangerous Diseases National Reference Laboratory in Almaty at −20°C within 72 h.

Serum samples were tested for the presence of IgG antibodies reactive to HTNV, DOBV, PUUV strains using enzyme-linked immunosorbent assay (ELISA) EUROLINE Anti-Hanta Profile 1 test kit1. Results were determined by assessing optical density (OD) using a microplate reader. Participants with OD ratios >0.8 were considered reactive. Positive serum samples were tested by Immunoblot Anti-Hanta Virus Pool 1 Eurasia test kit2 to identify the serotypes of hantaviruses. Bands with intensity from weak to very strong patterns were interpreted as positive.

The diagnostic test was performed and the results were interpreted according to the test-kit manufacturer’s instructions.

2.3 Ethical considerations

The study was approved by the Ethical Board of the National Center of Public Health, Ministry of Health of the Republic of Kazakhstan, under number 9/26.12.2022.

Written informed consent was obtained for all participants involved in the study. Children were not interviewed. Special considerations, if applicable, were addressed in accordance with ethical guidelines as approved by the Institutional Review Board (IRB) at the National Center of Public Health Care of The Ministry of Health of The Republic of Kazakhstan, based on international standards, including the Declaration of Helsinki and national regulations on biomedical research. Identifiable information and sensitive data were collected as necessary for research purposes, and safeguarded through encryption, restricted access, and secure storage protocols to ensure confidentiality and privacy.

2.4 Statistical analysis

Data cleaning and analysis was conducted in R version 4.3.1 statistical software. The questionnaire and laboratory databases were merged with Microsoft Excel using a unique participants’ identification number and then anonymized. Participants’ characteristics were summarized using descriptive statistics.

The outcome of interest was defined as the presence or absence of IgG antibodies reactive to hantavirus strains. The estimated seroprevalence and 95% confidence intervals were calculated for each group. Prevalence ratios (PR) and 95% confidence intervals (CI) were estimated by participant demographic, behavioral and environmental characteristics. The statistical significance of differences in prevalence between groups was determined using the χ2 and Fisher’s exact tests. After checking for multi-collinearity (phi coefficient), variables significant at p < 0.2 in bivariate analysis and known confounders (e.g., sex and age) were considered for multivariable Poisson regression.

3 Results

3.1 Recruitment flow

We selected 1,228 people from 14 villages in Boryly and Bayterek districts in West Kazakhstan region, of whom 971 (75.6%) agreed to participate and completed the questionnaire. Among those who consented, 921 had quality serum samples, and were included in the final study population.

3.2 Participant characteristics

Of the 921 participants 577 (63.0%) were female (Table 1). The median age was 53 years (standard deviation (SD): 16). And nearly one-half (48.0%) were aged 40–63 years. Among all participants 29.5% were retired, 27.7% were blue-collar workers, and 21.4% were unemployed. Most participants (72.0%) resided in single houses, 16.0% lived in houses with farm animals, and 12.0% in apartments.

Table 1
www.frontiersin.org

Table 1. Sociodemographic and residential characteristics of study participants, West Kazakhstan region, 2023 (Total N = 921).

When asked about the environment/habitat within 500 meters of their residence, 27.0% of participants lived near a forest, 9.6% near agricultural fields, and 0.9% (n = 8) near ponds. Nearly half of participants (48.0%) owned domestic cats, and one of five (21.0%) owned domestic poultry or cattle animals (sheep, goats or cows). Household habits showed that 80.0% of respondents have a pantry,3 93.8% clean their homes several times a month, and 66.0% use gloves most of the time during cleaning or gardening.

Rodent or rodent dropping sightings from July 2022 to July 2023 were reported by 38.0% (n = 351) of the participants. Of which (n = 351) the sightings near their home reported 78.6% and near their place of work reported 37.9%.

3.3 Seroprevalence and prior disease history

Hantavirus seroprevalence was 3.1% (n = 28, 95% Confidence interval (CI): 2.1–4.3). Of the 28 positives sera tested by Immunoblot, 14 had specific PUUV pattern,4 7 had non-specific patterns, 6 had cross-reactivity pattern (PUUV, HTNV, DOBV). One serum showed a specific reaction for the HTNV and DOBV antigen.

When we compared those who tested positive for Hantavirus to those who did not, none of the 28 who tested positive had a history of HFRS, recent febrile illness, rash, or other clinical symptoms/signs consistent with HFRS. In contrast, 3 participants among whom tested negative reported a history of HFRS (Table 2).

Table 2
www.frontiersin.org

Table 2. Clinical characteristic of study participants, West Kazakhstan region, 2023 (Total N = 921).

3.4 Seroprevalence and risk factors

Hantavirus seroprevalence did not statistically differ by sex (3.1% among females and 2.9% among males) (Table 3). The seroprevalence ranged from 2.3% among participants aged 40–63 years, 3.3% among 39 and younger and to 4.2% among those aged 64 and older but did not differ statistically by age. Office space workers5 had the highest seroprevalence among the different types of employment status, with 4.5%.

Table 3
www.frontiersin.org

Table 3. Variables associated with hantavirus seroprevalence, West Kazakhstan, 2023 (Total N = 921).

Participants who reported infrequent use of gloves while gardening had seroprevalence of 4.5% (95% CI: 2.6–7.6), compared to those who used gloves most of the time, 2.3% (95% CI: 1.3–3.9). The prevalence among participants living near ponds was 25.0% (n = 2/8, 95% CI: 4.5–64.0).

There was no significant difference in seroprevalence among those who had noticed rodent activity or droppings in their homes or workplaces in the preceding year compared to those that did not observe rodent activity (p > 0.05).

In multivariable Poisson regression, occupation was significantly associated with seropositivity. Specifically, office space workers (PR = 7.3, 95%CI 1.3–53.5, p = 0.029) had increased risk compared to those who are unemployed. Risk was also increased for people who lived near ponds (PR = 11.5, 95%CI 1.6–54.7, p = 0.005) compared to those who did not live near a pond.

Risk was lower for people who regularly used gloves while gardening compared to those who not (PR = 0.4, 95% CI 0.2–1.0), though not significant at (p < 0.05).

4 Discussion

Prior to our investigation, the seroprevalence of hantavirus infection among people living in West Kazakhstan was unknown. We found that approximately 3 in 100 adults had serologic evidence of exposure to hantavirus. Considering the Euroimmun test employed in our study, it is possible that our seroprevalence estimate is slightly conservative, as the test may not detect all true positive cases. However, in several studies which used the Euroimmun test for detecting IgG antibodies to hantaviruses demonstrated higher sensitivity and specificity (19, 20). Even with this potential underestimation, our findings suggest that the current passive case reporting surveillance system for hantaviruses likely underestimates true disease burden given that only 251 cases have ever been reported in this region with nearly 800,000 inhabitants.

Other important consideration is using the test pool sensitive to PUUV, HTNV and DOBV hantavirus strains. Although Tula virus (TULV) has been detected in West Kazakhstan, as documented by Tukhanova et al. (14), historically, PUUV has been the primary hantavirus circulating in West Kazakhstan, with its presence well-documented in routine surveillance. Yet the relatively low number of reported human TULV infections was registered in the region, the focus of our study was on clinically significant strains, as they pose a higher risk of severe disease (6).

Additionally, population mobility may further influence the observed seroprevalence. Seasonal labor migration, particularly among men traveling to neighboring regions for work in the oil industry, followed by engagement in manual labor upon their return, may increase exposure to hantavirus (21). These migratory patterns could result in the exclusion of higher-risk individuals from our sample, potentially contributing to the underestimation of seroprevalence.

Our findings are consistent with typical patterns of hantavirus epidemiology (22). Higher seroprevalence was noted among residents near agricultural fields and ponds that are essential for rodents’ life cycles, which concise with other studies (23, 24). People who were seropositive lived in areas that are common habitats for the common vole – the main reservoir of infection in the region (11).

Participants reported high frequency of household practices and animal ownership that are associated with hantavirus exposure. However, we did not detect a significant association of these with hantavirus seroprevalence. A study by Wang et al. (25) found that infrequent human activity in poorly ventilated spare rooms may facilitate rodent reproduction, increasing the risk of hantavirus transmission through inhalation of infected aerosols. Some studies (9, 26) linked food contamination by rat excreta to increased risk, emphasizing the importance of proper food handling and storage practices. People can also become infected with hantavirus by touching their mouth or nose after handling contaminated materials. In our study, we did observe lower hantavirus seroprevalence among people who reported always using gloves when cleaning or gardening compared to those who did not, though this difference was not significant.

Among participants that tested positive, none reported prior hantavirus diagnosis, and none recalled having had symptoms consistent with hantavirus, suggesting a predominance of milder forms of the disease (3). A study in West Kazakhstan region found that individuals at risk of multiple or repeat infections, may develop immunity, which could result in mild or asymptomatic hantavirus infection (11). The lack of symptoms among IgG positive participants could also be explained by persistence of antibodies for up to a year or more after past illness (27, 28). It is important to note that PUUV infection, identified through immunoblot testing, usually results in mild illness with spontaneous full recovery. However, while most patients experience full recovery of renal function, there is a risk of delayed development of renal complications, including chronic renal impairment (11, 2931).

Unexpectedly, our study identified higher prevalence of hantavirus antibodies among individuals reporting limited outdoor activities compared to those who reported outdoor activities and those engaged in office occupational roles versus unemployed. While it is expected that farm workers will have higher seroprevalence rates than the other groups (25, 32, 33), our results indicate diverse activities or behaviors among office workers in West Kazakhstan region. They may encounter hantavirus-carrying rodents potentially in and around their workplaces (34, 35), with the likely exposure factor being enclosed (office building) spaces where contamination with viral particle aerosols is higher (36). While we did not specifically ask about the sanitary conditions in their workplaces, it is known that in the rural areas where the study was conducted, these “offices” are old 1–2 story structures, with often poor sanitation conditions, and increase the likelihood of contact with rodents. This finding may be an outlier but warrants further consideration and study.

Our study was subject to several limitations. First, the study observed low participation among men due to seasonal work, who may be at greater risk. Since the response rate was 75.6%, participation bias may have affected our results. Second, our study was underpowered to detect differences between groups at seroprevalence of 3.1%. Third, our findings were potentially subject to recall bias because participants may fail to remember specific exposures or mild symptoms. Fourth, the seroprevalence estimate in our study may be slightly underestimated due to the sensitivity (88.2%) and specificity (94.1%) of the Euroimmun test used. The inability to detect all true positive cases remains a limitation and could contribute to a conservative estimate of seroprevalence.

To reduce the effect of these limitations, systematic random sampling was employed, enhancing the reliability and validity of the study findings by reducing selection bias. We also used local family nurses for the recruitment process leveraging their frequent contact and trust in the community, which likely increased engagement in the study. In addition, we cross-referenced reported symptoms with medical records when possible. While our test was not the same used routinely in the country by public health authorities, the Euroimmun test we used has documented high sensitivity and specificity, giving us confidence in our results. The study encompassed two endemic districts in the West Kazakhstan region, providing a broad and representative understanding of the hantavirus seroprevalence in these key areas.

5 Conclusion

In conclusion, we found small proportion of adults in rural West Kazakhstan have evidence of exposure to hantavirus. We identified potential occupational and environmental exposures for hantavirus infection. We also identified the high prevalence of rodent activity in people’s homes and places of work. Poor housing conditions, especially in rural areas, were also found to contribute to higher infection risk. These findings emphasize the need to improve rodent control in the workplaces, home and surrounding habitats to mitigate the risk of hantavirus transmission. Public health interventions should focus on educating the public about the risks of rodent exposure and promoting preventive practices and sanitation.

Our study also highlights that reported cases likely underestimate the true incidence of infection and cases. This underscores the need to complement passive surveillance with periodic seroprevalence studies, including expanding the geographical coverage to additional districts, to gain a more accurate understanding of hantavirus circulation in the region. Establishing more laboratories equipped with capacity to conduct hantavirus testing, alongside educating healthcare providers can improve case detection.

Finally, migratory patterns and seasonal occupational mobility also potentially contribute to the underestimation of seroprevalence. Further studies that account for seasonal and occupational mobility are needed to better assess its impact on hantavirus exposure in the region. Given potential renal complications of hantavirus infection, we propose exploring the possibility of a targeted serosurvey among patients with chronic kidney disease compared to the general population. Observing higher hantavirus antibody prevalence in Chronic kidney disease (CKD) patients could provide insights into its potential contribution to CKD in the region. Understanding hantavirus transmission dynamics and addressing local risk factors through tailored public health measures are crucial for reducing infection risks and improving health outcomes in affected populations.

Data availability statement

The datasets presented in this article are not readily available because the data supporting the findings of this study are restricted due to Kazakhstan national legislation rules pertaining to especially dangerous infections. Official requests for the data can be made on request to the government of Kazakhstan. Requests to access the datasets should be directed to corresponding author, Ulyana Gubareva, dWx5YW5hLjkzNTVAZ21haWwuY29t.

Ethics statement

The studies involving humans were approved by Ethical Board of the National Center of Public Health, Ministry of Health of the Republic of Kazakhstan. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

UG: Formal analysis, Methodology, Project administration, Software, Visualization, Writing – original draft, Writing – review & editing. RH: Methodology, Supervision, Writing – review & editing. DN: Methodology, Supervision, Writing – review & editing. NuT: Data curation, Formal analysis, Methodology, Software, Validation, Writing – original draft. EU: Data curation, Methodology, Writing – review & editing. ZS: Data curation, Formal analysis, Writing – original draft, Writing – review & editing. ZT: Data curation, Formal analysis, Writing – original draft. NaT: Data curation, Investigation, Writing – original draft, Formal analysis. NM: Data curation, Investigation, Validation, Writing – original draft. MS: Conceptualization, Writing – review & editing. AL: Conceptualization, Methodology, Supervision, Writing – review & editing. GC: Conceptualization, Funding acquisition, Writing – review & editing. FA: Conceptualization, Funding acquisition, Supervision, Writing – review & editing. EM: Conceptualization, Supervision, Writing – review & editing.

Funding

The authors declare that financial support was received for the research, authorship, and/or publication of this article. The study was conducted under the TEPHINET and the Abbott Pandemic Defense Coalition FETP Fellowship 2022–2023 Cycle. The cost of publication was supported by a grant funded by Abbott. The funder had no role in the study design, data collection, analysis, interpretation of data, writing of this article, or the decision to submit it for publication.

Acknowledgments

We express our gratitude to the Bayterek and Boryly inpatient hospital, fellow colleagues in the Ural anti-plague station, Local Healthcare departments and the Ministry of Healthcare of Republic of Kazakhstan for supporting data collection for this study. We express our gratitude to Abbott, The Task Force for Global Health, Inc. and TEPHINET for financial support.

Conflict of interest

The authors declare the following potential competing interests: Francisco Averhoff is a Medical director of Infectious Diseases Research and the Abbott Pandemic Defense Coalition, Abbott Diagnostics. Gavin Cloherty is a Head of Infectious Disease Research and the Abbott Pandemic Defense Coalition, Abbott Diagnostics. Alan L. Landay is a consultant for Abbott Diagnostics. Abbott provided funding for this study; however, the funder had no role in the study design, collection, analysis, interpretation of data, writing of this article, or the decision to submit it for publication.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The authors declare that no Gen AI was used in the creation of this manuscript.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Author disclaimer

Publication contents are solely the responsibility of the authors and do not necessarily represent the official views of Abbott, The Task Force for Global Health, Inc. or TEPHINET, or the U.S. Centers for Disease Control and Prevention.

Footnotes

1. ^EUROLINE Anti-Hanta Profile 1 (IgG) (EUROIMMUN AG, Lübeck, Germany) test kit has previously been found to be sensitive (100%) and specific (100%) in study with 157 pre-characterized patient samples; and to be sensitive (88.2%) and specific (94.1%) in a study with thirty-nine pre-characterized patient samples. Borderline results were not included in the calculation.

2. ^Anti-Hanta Virus Pool 1 “Eurasia” ELISA (EUROIMMUN AG, Lübeck, Germany) test sensitivity and specificity amounted to 92.5 and 88.9%, respectively.

3. ^Pantry - a room or closet in which food, groceries, and other provisions, or silverware, dishes, etc., are kept.

4. ^By comparing intensities of color reaction of sample band to control band.

5. ^In the rural areas where the study was conducted, these “offices” are old 1–2 story structures, not modern business buildings, with poor sanitation conditions, and high likelihood of contact with rodents.

References

1. NCBI Hantavirus Infection: a review and global update. (2008). Available at: http://www.ncbi.nlm.nih.gov/ICTVdb/Ictv/ (Accessed April 2, 2024).

Google Scholar

2. CDC We Were There - Of Mice and Men: Discovering a Deadly Hantavirus in the Americas. (2024) Available at: https://www.cdc.gov/os/wewerethere/hantavirus/index.html (Accessed April 2, 2024).

Google Scholar

3. Sehgal, A, Mehta, S, Sahay, K, Martynova, E, Rizvanov, A, Baranwal, M, et al. Hemorrhagic fever with renal syndrome in Asia: history, pathogenesis, diagnosis, treatment, and prevention. Viruses. (2023) 15, 561:561. doi: 10.3390/V15020561

Crossref Full Text | Google Scholar

4. Tkachenko, E, Kurashova, S, Balkina, A, Ivanov, A, Egorova, M, Leonovich, O, et al. Cases of hemorrhagic fever with renal syndrome in Russia during 2000–2022. Viruses. (2023) 15:537. doi: 10.3390/V15071537

PubMed Abstract | Crossref Full Text | Google Scholar

5. Luo, Y, Lv, H, Yan, H, Zhu, C, Ai, L, Li, W, et al. Meteorological change and hemorrhagic fever with renal syndrome epidemic in China, 2004–2018. Sci Rep. (2022) 12:1–12. doi: 10.1038/s41598-022-23945-9

Crossref Full Text | Google Scholar

6. Jiang, H, Du, H, Wang, LM, Wang, PZ, and Bai, XF. Hemorrhagic fever with renal syndrome: pathogenesis and clinical picture. Front Cell Infect Microbiol. (2016) 6:1. doi: 10.3389/FCIMB.2016.00001

PubMed Abstract | Crossref Full Text | Google Scholar

7. Chen, RX, Gong, HY, Wang, X, Sun, MH, Ji, YF, Tan, SM, et al. Zoonotic Hantaviridae with global public health significance. Viruses. (2023) 15:1705. doi: 10.3390/V15081705

Crossref Full Text | Google Scholar

8. Noh, JY, Jung, J, and Song, JW. Hemorrhagic fever with renal syndrome. Infect Chemother. (2019) 51:405–13. doi: 10.3947/IC.2019.51.4.405

PubMed Abstract | Crossref Full Text | Google Scholar

9. Wu, G, Xia, Z, Wang, F, Wu, J, Cheng, D, Chen, X, et al. Investigation on risk factors of haemorrhagic fever with renal syndrome (HFRS) in Xuancheng City in Anhui Province, mainland China. Epidemiol Infect. (2020) 148:e248. doi: 10.1017/S0950268820002344

PubMed Abstract | Crossref Full Text | Google Scholar

10. Schmaljohn, C, and Hjelle, B. Hantaviruses: a global disease problem. Emerg Infect Dis. (1997) 3:95–104. doi: 10.3201/EID0302.970202

PubMed Abstract | Crossref Full Text | Google Scholar

11. Grazhdanov, AK, Ayazbaev, TZ, Toporkov, AV, Bidashko, FG, Zakharov, AV, Belonozhkina, LB, et al. О выявлении новых природных очагов актуальных инфекционных болезней на западе Казахстана. Проблемы особо опасных инфекций. (2014) 20–4. doi: 10.21055/0370-1069-2014-3-20-24

Crossref Full Text | Google Scholar

12. Атшабар, ББ, Бурделов, ЛА, Избанова, УА, Лухнова, ЛЮ, Мека-Меченко, ТВ, Мека-Меченко, ВГ, et al. Паспорт регионов Казахстана по особо опасным инфекциям. Карантинные и зоонозные инфекции в Казахстане. (2014) 1:24–5.

Google Scholar

13. Tukhanova, N, Shin, A, Abdiyeva, K, Turebekov, N, Yeraliyeva, L, Yegemberdiyeva, R, et al. Serological investigation of orthohantaviruses in patients with fever of unknown origin in Kazakhstan. Zoonoses Public Health. (2020) 67:271–9. doi: 10.1111/zph.12683

PubMed Abstract | Crossref Full Text | Google Scholar

14. Tukhanova, N, Shin, A, Turebekov, N, Nurmakhanov, T, Abdiyeva, K, Shevtsov, A, et al. Molecular characterisation and phylogeny of Tula virus in Kazakhstan. Viruses. (2022) 14:1258. doi: 10.3390/v14061258

PubMed Abstract | Crossref Full Text | Google Scholar

15. Plyusnina, A, Laakkonen, J, Niemimaa, J, Henttonen, H, and Plyusnin, A. New genetic lineage of Tula hantavirus in Microtus arvalis obscurus in eastern Kazakhstan. Open Virol J. (2008) 2:32–6. doi: 10.2174/1874357900802010032

PubMed Abstract | Crossref Full Text | Google Scholar

16. Arahirwa, V, Tyrlik, K, Abernathy, H, Cassidy, C, Alejo, A, Mansour, O, et al. Impact of the COVID-19 pandemic on delays in diagnosis and treatment of tick-borne diseases endemic to southeastern USA. Parasit Vectors. (2023) 16:295. doi: 10.1186/S13071-023-05917-8

PubMed Abstract | Crossref Full Text | Google Scholar

17. Dupont, WD, and Plummer, WD Jr. Power and sample size calculations. A review and computer program. Control Clin Trials. (1990) 11:116–28. doi: 10.1016/0197-2456(90)90005-m

PubMed Abstract | Crossref Full Text | Google Scholar

18. KoboToolbox Harvard Humanitarian Initiative. (2023). Available at: https://www.kobotoolbox.org/ (Accessed November 5, 2023).

Google Scholar

19. Duggan, J, Close, R, Mccann, L, Wright, D, Keys, M, Mccarthy, N, et al. A seroprevalence study to determine the frequency of hantavirus infection in people exposed to wild and pet fancy rats in England. Epidemiol Infect. (2017) 145:2458–65. doi: 10.1017/S0950268817001480

PubMed Abstract | Crossref Full Text | Google Scholar

20. Lederer, S, Lattwein, E, Hanke, M, Sonnenberg, K, Stoecker, W, Lundkvist, Å, et al. Correction: indirect immunofluorescence assay for the simultaneous detection of antibodies against clinically important old and New World hantaviruses. PLoS Negl Trop Dis. (2020) 14:e0008864. doi: 10.1371/journal.pntd.0008864

PubMed Abstract | Crossref Full Text | Google Scholar

21. Khamzin, AS, Khamzina, ZA, Aldabergenova, NA, Koshpenbetov, BM, and Buribayev, YA. Labor migration: a view from Kazakhstan. J Educ Soc Res. (2023) 13:84. doi: 10.36941/jesr-2023-0092

Crossref Full Text | Google Scholar

22. Tortosa, F, Perre, F, Tognetti, C, Lossetti, L, Carrasco, G, Guaresti, G, et al. Seroprevalence of hantavirus infection in non-epidemic settings over four decades: a systematic review and meta-analysis. BMC Public Health. (2024) 24:2553. doi: 10.1186/s12889-024-20014-w

PubMed Abstract | Crossref Full Text | Google Scholar

23. Singh, S, Numan, A, Sharma, D, Shukla, R, Alexander, A, Jain, GK, et al. Epidemiology, virology and clinical aspects of hantavirus infections: an overview. Int J Environ Health Res. (2022) 32:1815–26. doi: 10.1080/09603123.2021.1917527

PubMed Abstract | Crossref Full Text | Google Scholar

24. Jonsson, CB, Figueiredo, LTM, and Vapalahti, O. A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev. (2010) 23:412–41. doi: 10.1128/CMR.00062-09

PubMed Abstract | Crossref Full Text | Google Scholar

25. Wang, X, Shen, W, Qin, Y, Ying, L, Li, H, Lu, J, et al. A case-control study on the risk factors for hemorrhagic fever with renal syndrome. BMC Infect Dis. (2020) 20:1–7. doi: 10.1186/S12879-020-4830-5/TABLES/5

Crossref Full Text | Google Scholar

26. Klempa, B, Koivogui, L, Sylla, O, Koulemou, K, Auste, B, Krüger, DH, et al. Serological evidence of human hantavirus infections in Guinea, West Africa. J Infect Dis. (2010) 201:1031–4. doi: 10.1086/651169

PubMed Abstract | Crossref Full Text | Google Scholar

27. Latus, J, Schwab, M, Tacconelli, E, Pieper, FM, Wegener, D, Dippon, J, et al. Clinical course and long-term outcome of hantavirus-associated Nephropathia Epidemica. Germany Emerg Infect Dis. (2015) 21:76–83. doi: 10.3201/EID2101.140861

PubMed Abstract | Crossref Full Text | Google Scholar

28. CDC Diagnostics Hantavirus. Available at: https://www.cdc.gov/hantavirus/technical/hps/diagnostics.html (Accessed April 2, 2024).

Google Scholar

29. Егембердиева, РА. Геморрагическая лихорадка с почечным синдромом в Казахстане. Kyrgyzstan Medicine. (2011) 5:35–7.

Google Scholar

30. Novo, R, Gagnadoux, MF, Le Guenno, Y, Gubler, MC, Niaudet, P, Guyot, C, et al. Chronic renal failure after Puumala virus infection. Pediatr Nephrol. (1999) 13:934–5. doi: 10.1007/s004670050733

PubMed Abstract | Crossref Full Text | Google Scholar

31. Vaheri, A, Smura, T, Vauhkonen, H, Hepojoki, J, Sironen, T, Strandin, T, et al. Puumala hantavirus infections show extensive variation in clinical outcome. Viruses. (2023) 15:805. doi: 10.3390/v15030805

PubMed Abstract | Crossref Full Text | Google Scholar

32. Mertens, M, Hofmann, J, Petraityte-Burneikiene, R, Ziller, M, Sasnauskas, K, Friedrich, R, et al. Seroprevalence study in forestry workers of a non-endemic region in eastern Germany reveals infections by Tula and Dobrava-Belgrade hantaviruses. Med Microbiol Immunol. (2011) 200:263–8. doi: 10.1007/s00430-011-0203-4

PubMed Abstract | Crossref Full Text | Google Scholar

33. Christova, I, Panayotova, E, Trifonova, I, Taseva, E, Hristova, T, and Ivanova, V. Country-wide seroprevalence studies on Crimean-Congo hemorrhagic fever and hantavirus infections in general population of Bulgaria. J Med Virol. (2017) 89:1720–5. doi: 10.1002/jmv.24868

PubMed Abstract | Crossref Full Text | Google Scholar

34. Riccò, M, Peruzzi, S, Ranzieri, S, and Magnavita, N. Occupational hantavirus infections in agricultural and forestry workers: a systematic review and Metanalysis. Viruses. (2021) 13:150. doi: 10.3390/V13112150

PubMed Abstract | Crossref Full Text | Google Scholar

35. Muñoz-Zanzi, C, Saavedra, F, Otth, C, Domancich, L, Hott, M, and Padula, P. Serological evidence of hantavirus infection in apparently healthy people from rural and slum communities in southern Chile. Viruses. (2015) 7:2006–13. doi: 10.3390/V7042006

PubMed Abstract | Crossref Full Text | Google Scholar

36. Childs, JE, Krebs, JW, Ksiazek, TG, Maupin, GO, Gage, KL, Rollin, PE, et al. A household-based, case-control study of environmental factors associated with hantavirus pulmonary syndrome in the southwestern United States. Am J Trop Med Hyg. (1995) 52:393–7. doi: 10.4269/AJTMH.1995.52.393

PubMed Abstract | Crossref Full Text | Google Scholar

Keywords: hantavirus, hemorrhagic fever renal syndrome, HFRS, hantavirus infection, rodent-borne diseases, West Kazakhstan

Citation: Gubareva U, Horth R, Nabirova D, Tukhanova N, Utegenova E, Shapiyeva Z, Turliyev Z, Tleumbetova N, Maykanov N, Smagul M, Landay AL, Cloherty G, Averhoff F and Maes EF (2025) Hantavirus antibody seroprevalence and risk factors among adults in West Kazakhstan, 2023. Front. Public Health. 12:1519117. doi: 10.3389/fpubh.2024.1519117

Received: 29 October 2024; Accepted: 27 December 2024;
Published: 16 January 2025.

Edited by:

Antonio Sarría-Santamera, Nazarbayev University, Kazakhstan

Reviewed by:

Fernando Tortosa, National University of Río Negro, Argentina
Inés Iglesias Rodriguez, Instituto Salud Global Barcelona (ISGlobal), Spain

Copyright © 2025 Gubareva, Horth, Nabirova, Tukhanova, Utegenova, Shapiyeva, Turliyev, Tleumbetova, Maykanov, Smagul, Landay, Cloherty, Averhoff and Maes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ulyana Gubareva, dWx5YW5hLjkzNTVAZ21haWwuY29t

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.